BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, November 26, 2024
See today's BioWorld Asia
Home
» Other news to note for Feb. 4, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Feb. 4, 2020
Feb. 4, 2020
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Advaccine, Anticancer, Asahi Kasei, Aspen, Avacta, BGI, Biolexis, Celularity, Clover, Curetis, Curevac, Daewoong, Duke-National University, Horizon, Inovio, Novartis, Outlook, Oxford Gene Technology, Sandoz, Sorrento, Sysmex, Takeda, Veloxis, Wuhan Institute of Virology, Wuxi Biologics.
BioWorld Asia
Briefs
Other news to note
Coronavirus